These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8196272

  • 41. Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin.
    Manning M, Sawyer WH.
    J Recept Res; 1993; 13(1-4):195-214. PubMed ID: 8383753
    [Abstract] [Full Text] [Related]

  • 42. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.
    Maggi M, Malozowski S, Kassis S, Guardabasso V, Rodbard D.
    Endocrinology; 1987 Mar; 120(3):986-94. PubMed ID: 3026794
    [Abstract] [Full Text] [Related]

  • 43. Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens.
    Robinzon B, Koike TI, Marks PA.
    Peptides; 1994 Mar; 15(8):1407-13. PubMed ID: 7700844
    [Abstract] [Full Text] [Related]

  • 44. Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat.
    MacNeil BJ, Jansen AH, Greenberg AH, Nance DM.
    Brain Behav Immun; 2003 Dec; 17(6):442-52. PubMed ID: 14583236
    [Abstract] [Full Text] [Related]

  • 45. Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats.
    Adachi K, Majima M, Katori M, Nishijima M.
    Jpn J Pharmacol; 1995 Mar; 67(3):243-52. PubMed ID: 7630042
    [Abstract] [Full Text] [Related]

  • 46. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY, Wo NC, Cheng LL, Manning M.
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [Abstract] [Full Text] [Related]

  • 47. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors.
    Maggi M, Del Carlo P, Fantoni G, Giannini S, Torrisi C, Casparis D, Massi G, Serio M.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1142-54. PubMed ID: 2156888
    [Abstract] [Full Text] [Related]

  • 48. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M, Melin P, Maggi M.
    Adv Exp Med Biol; 1995 Apr; 395():595-600. PubMed ID: 8714023
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensis.
    Pettibone DJ, Clineschmidt BV, Anderson PS, Freidinger RM, Lundell GF, Koupal LR, Schwartz CD, Williamson JM, Goetz MA, Hensens OD.
    Endocrinology; 1989 Jul; 125(1):217-22. PubMed ID: 2544402
    [Abstract] [Full Text] [Related]

  • 54. Electrophysiological responses to oxytocin and ATP in monolayers of a human sweat gland cell line.
    Ring A, Mörk AC.
    Biochem Biophys Res Commun; 1997 May 08; 234(1):30-4. PubMed ID: 9168954
    [Abstract] [Full Text] [Related]

  • 55. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C, Haywood JR.
    J Pharmacol Exp Ther; 1986 Aug 08; 238(2):492-6. PubMed ID: 2874211
    [Abstract] [Full Text] [Related]

  • 56. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G.
    Prog Brain Res; 2008 Aug 08; 170():473-512. PubMed ID: 18655903
    [Abstract] [Full Text] [Related]

  • 57. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.
    Schlosser SF, Almeida OF, Patchev VK, Yassouridis A, Elands J.
    Endocrinology; 1994 Nov 08; 135(5):2058-63. PubMed ID: 7956927
    [Abstract] [Full Text] [Related]

  • 58. Antagonists for the human oxytocin receptor: an in vitro study.
    Maggi M, Fantoni G, Baldi E, Cioni A, Rossi S, Vannelli GB, Melin P, Akerlund M, Serio M.
    J Reprod Fertil; 1994 Jul 08; 101(2):345-52. PubMed ID: 7932368
    [Abstract] [Full Text] [Related]

  • 59. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M, Kassis S, Malozowski S, Guardabasso V, Rodbard D.
    Proc Natl Acad Sci U S A; 1986 Dec 08; 83(23):8824-8. PubMed ID: 2947237
    [Abstract] [Full Text] [Related]

  • 60. Neurohypophyseal hormone receptors in the rat thymus, spleen, and lymphocytes.
    Elands J, Resink A, De Kloet ER.
    Endocrinology; 1990 May 08; 126(5):2703-10. PubMed ID: 2158433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.